Appeals Court Allows Sanofi, Regeneron to Continue Selling Cholesterol Drug

A U.S. federal appeals court said Sanofi SA and partner Regeneron Pharmaceuticals Inc. can keep selling their cholesterol drug while they challenge a patent-infringement ruling by a lower court that threatened to halt sales.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news